-

The Law Offices of Frank R. Cruz Announces Investigation of TMC the metals company Inc. (TMC) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of TMC the metals company Inc. (“TMC” or the “Company”) (NASDAQ: TMC) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On October 6, 2021, Bonitas Research published a report alleging, among other things, that TMC had siphoned $43 million to insiders by overpaying for Tonga Offshore Mineral License. The license had previously been owned by Nautilus Minerals Inc., which “valued the TOML exploration license in its historical annual reports at zero.”

On this news, the Company’s stock price fell $0.32, or 7%, to close at $4.14 per share on October 6, 2021, thereby injuring investors.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased TMC securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

The Law Offices of Frank R. Cruz

NASDAQ:TMC

Release Summary
The Law Offices of Frank R. Cruz Announces Investigation of TMC the metals company Inc. (TMC) on Behalf of Investors
Release Versions
$Cashtags

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

Social Media Profiles
More News From The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz Announces Investigation of Stride, Inc. (LRN) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) concerning whether the board breached its fiduciary duties to shareholders. If you are a shareholder, click HERE to participate. On September 14, 2025, Simply Wall St. published a report stating that the Gallup-McKinley County Schools Board of Education had filed a complaint against Stride, alleging fraud, decepti...

The Law Offices of Frank R. Cruz Announces Investigation of Fluor Corporation (FLR) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Fluor Corporation (“Fluor” or the “Company”) (NYSE: FLR) concerning whether the board breached its fiduciary duties to shareholders. If you are a shareholder, click HERE to participate. On August 1, 2025, Fluor released its second quarter 2025 financial results, missing consensus estimates, citing growing costs in multiple infrastructure projects due to subcontracto...

The Law Offices of Frank R. Cruz Announces Investigation of Cytokinetics, Incorporated (CYTK) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK) concerning whether the board breached its fiduciary duties to shareholders. If you are a shareholder, click HERE to participate. On May 1, 2025, Cytokinetics disclosed that the FDA has extended the review period for its cardiac myosin inhibitor drug, aficamten, by three months, citing additi...
Back to Newsroom